Cargando…

Hereditary cancer risk assessment: insights and perspectives for the Next-Generation Sequencing era

Hereditary cancer risk assessment is a multidisciplinary and dynamic process, with the purpose of estimating probabilities of germline mutations in cancer susceptibility genes and assessing empiric risks of cancer based on personal and family histories, in order to offer clinical and molecular diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomy, Israel, Diz, Maria Del Pilar Estevez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Genética 2016
Materias:	Special Oncogenetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910549/ https://www.ncbi.nlm.nih.gov/pubmed/27192130 http://dx.doi.org/10.1590/1678-4685-GMB-2014-0346

Ejemplares similares

CDH1 mutations in gastric cancer patients from northern Brazil identified by Next- Generation Sequencing (NGS)
por: El-Husny, Antonette, et al.
Publicado: (2016)

The Development of the Study of Hereditary Cancer in South America
por: Rossi, Benedito Mauro, et al.
Publicado: (2016)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in Brazil
por: Ashton-Prolla, Patricia, et al.
Publicado: (2016)

Self-reported cancer family history is a useful tool for identification of individuals at risk of hereditary cancer predisposition syndrome at primary care centers in middle-income settings: a longitudinal study
por: Flória-Santos, Milena, et al.
Publicado: (2016)

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2016)

Editorial: Hereditary Cancer Risk Assessment: New Perspectives and Challenges for the Next-Gen Sequencing Era
por: Gomy, Israel
Publicado: (2016)

Hereditary cancer risk assessment: essential tools for a better approach
por: Gomy, Israel, et al.
Publicado: (2013)

Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation
por: Andrade, Kelvin C., et al.
Publicado: (2016)

Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H inTP53
por: Fitarelli-Kiehl, Mariana, et al.
Publicado: (2016)

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital
por: Palmero, Edenir I., et al.
Publicado: (2016)

Prevalence of Café-au-Lait Spots in children with solid tumors
por: dos Santos, Anna Claudia Evangelista, et al.
Publicado: (2016)

Ovarian cancer risk assessment in the era of next-generation sequencing
por: Bonadio, Renata Colombo, et al.
Publicado: (2020)

Hereditary Cancer Risk Assessment: Challenges for the Next-Gen Sequencing Era
por: Pinheiro, Hugo, et al.
Publicado: (2015)

Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing
por: Hensiek, Anke, et al.
Publicado: (2014)

Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing
por: Stanislaw, Christine, et al.
Publicado: (2016)

Perspectives of Integrative Cancer Genomics in Next Generation Sequencing Era
por: Kwon, So Mee, et al.
Publicado: (2012)

Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
por: Simoes Correa-Galendi, Julia, et al.
Publicado: (2020)

P1527: NEXT GENERATION SEQUENCING IN HEREDITARY SPHEROCYTOSIS DIAGNOSIS
por: García Feria, A., et al.
Publicado: (2022)

Disease vectors in the era of next generation sequencing
por: Rinker, David C., et al.
Publicado: (2016)

Unrevealed mosaicism in the next-generation sequencing era
por: Gajecka, Marzena
Publicado: (2015)

New Era for Next-Generation Sequencing in Japan
por: Takeda, Masayuki, et al.
Publicado: (2019)

Metabolic Myopathies in the Era of Next-Generation Sequencing
por: Urtizberea, Jon Andoni, et al.
Publicado: (2023)

Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies
por: Barrios, Carlos, et al.
Publicado: (2021)

Progress and prospects of next-generation sequencing testing for inherited retinal dystrophy
por: Chiang, John (Pei-Wen), et al.
Publicado: (2015)

Perspectives on PARP Inhibitor Combinations for Ovarian Cancer
por: Bonadio, Renata Colombo, et al.
Publicado: (2021)

Targeted Next Generation Sequencing (NGS) to Diagnose Hereditary Hemolytic Anemias
por: Bharadwaj, Rishab, et al.
Publicado: (2020)

Next-generation sequencing and the era of personal Y genomes
por: Ayub, Qasim, et al.
Publicado: (2010)

Management of Incidental Findings in the Era of Next-generation Sequencing
por: Blackburn, Heather L., et al.
Publicado: (2015)

Clinical care models in the era of next‐generation sequencing
por: Slavotinek, Anne
Publicado: (2016)

Principles of Genetic Counseling in the Era of Next-Generation Sequencing
por: Yang, Mina, et al.
Publicado: (2018)

Molecular Modelling Hurdle in the Next-Generation Sequencing Era
por: Fernandez, Guerau, et al.
Publicado: (2022)

Base-calling for next-generation sequencing platforms
por: Ledergerber, Christian, et al.
Publicado: (2011)

Detecting genetic variations in hereditary retinal dystrophies with next-generation sequencing technology
por: Jin, Xin, et al.
Publicado: (2014)

Genetic analysis of Iranian family with hereditary cardiac arrhythmias by next generation sequencing
por: Asadi, Marzieh, et al.
Publicado: (2016)

Diagnostic yield of targeted next-generation sequencing for pediatric hereditary hemolytic anemia
por: Choi, Yu Jeong, et al.
Publicado: (2023)

Inherited platelet disorders: Insight from platelet genomics using next-generation sequencing
por: Maclachlan, Annabel, et al.
Publicado: (2017)

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)
por: Naito, Yoichi, et al.
Publicado: (2020)

Analytical Tools and Databases for Metagenomics in the Next-Generation Sequencing Era
por: Kim, Mincheol, et al.
Publicado: (2013)

Genomics in 2012: challenges and opportunities in the next generation sequencing era
por: Zhao, Zhongming, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qs7od31rflbb87u57uklc8b9ta